Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01574131 · ClinicalTrials.gov registry record · Phase 4

Acute and Long-Term Outcome Investigations of Fenofibrate on Severely Burned Patients

A Phase 4 study, sponsored by The University of Texas Medical Branch, Galveston.

Terminated
Registry status
Phase 4
Development phase
3
Enrollment target

NCT01574131 is a Phase 4 study that was terminated before completion, run by The University of Texas Medical Branch, Galveston. The registered enrollment target is 3 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01574131, a Phase 4 study, was terminated before completion, sponsored by The University of Texas Medical Branch, Galveston.

TERMINATED
Registry status
Phase 4
Development phase
3 participants
Enrollment target

Study Summary

The purpose of this study is to learn the following: whether long-term treatment (6 months) with fenofibrate will decrease burn related sugar and fat increased in the blood and help prevent muscle loss and improve wound healing.

Interventions

  • DRUG Fenofibrate
  • DRUG Sugar Pill

Trial Details

FieldValue
Enrollment Target 3 participants
Start Date 2012-05
Est. Completion 2016-02
Phase Phase 4

What the Registry Record Tells You About NCT01574131

The ClinicalTrials.gov registry entry for NCT01574131 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Medical Branch, Galveston, which has 203 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Fenofibrate is the first listed.

NCT01574131 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01574131 about?

NCT01574131 is a clinical study titled "Acute and Long-Term Outcome Investigations of Fenofibrate on Severely Burned Patients". The purpose of this study is to learn the following: whether long-term treatment (6 months) with fenofibrate will decrease burn related sugar and fat increased in the blood and help prevent muscle loss and improve wound healing.

What is the current status of trial NCT01574131?

This trial is currently terminated. It is a Phase 4 study. The enrollment target is 3 participants. The study started on 2012-05. Estimated completion is 2016-02.

What interventions are being tested in trial NCT01574131?

The interventions under investigation include: Fenofibrate (DRUG), Sugar Pill (DRUG).

Who is sponsoring clinical trial NCT01574131?

This trial is sponsored by The University of Texas Medical Branch, Galveston, which has 203 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.